The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Feature | Specification |
---|---|
Application | Newborn Screening |
The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
This assay measures muscle specific creatine kinase in dried blood spots, helping to detect newborns affected by Duchenne Muscular Dystrophy.
Revvity's GSP® Neonatal Creatine Kinase –MM kit is an immunoassay for measuring CK-MM in dried blood spot samples of newborn babies. As the assay measures the muscle specific isoform, it enables the screening process to find the babies affected by DMD. The kit is available on Revvity's GSP® instrument, a fully automated, high throughput biochemical analyzer.
Benefits of the assay:
Application |
Newborn Screening
|
---|---|
Brand |
GSP®
|
Detection Modality |
Enzymatic
|
Disorders |
Duchenne Muscular Dystrophy
|
Instrument Compatibility |
GSP
|
Quantity |
500 tests
|
Sample Type |
Dried blood spots
|
Technology |
Enzymatic
|
Unit Size |
1 kit
|
Are you looking for resources, click on the resource type to explore further.
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.